• Visiongain Publishes RNA Analysis/Transcriptomics Market Report 2020-2030

    Rising preference for personalised medicine in developed as well developing economies coupled with increasing investment by biotechnological and pharmaceutical companies for drug discovery is expected to increase RNA analysis/transcriptomics market concentration over the forecast period. In order to increase the reliability and success rate of the drug production process.

  • Visiongain Publishes Plasma Therapy Market Report 2021-2031

    The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.

  • Visiongain Publishes Precision Cancer Diagnostic Test Market Report 2021-2031

    Molecular diagnostics are rapidly transforming drug development and patient selection: trials with biomarkers have higher success rates than those without, and combining patients with a proven biomarker allows efficient trials to be conducted in rare cancers.

  • Visiongain Publishes Top 50 Biosimilar Drug Manufacturers 2021

    Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.

  • Visiongain Publishes Advanced Therapy Medicinal Products (ATMP) Market Report 2021-2031

    Currently, the ATMP market is at a nascent stage and is expected to flourish during near future owing to increasing research and development activities and rising use of ATMP therapy products in treatment areas with low or no alternative treatment options support the market growth